Home » Newsletters » BioWorld

BioWorld

May 16, 1996

View Archived Issues

HYBRIDON'S ANTISENSE STRIKES OUT KEY MOLECULE CAUSING BLINDNESS OF

RHONE-POULENC RORER'S TAXOTERE GETS FDA MARKET APPROVAL

OTHER NEWS TO NOTE

EUROPEAN PATENT DISCLOSURES

UMASS SIGNS $42M DEAL FOR DNA-BASED VACCINES

SECOND GENETICS INSTITUTE PHASE II TRIAL POSITIVE FOR PLATELET GROWTH

MICROCIDE IPO GENERATES $35M, JUMPS 30 PERCENT OPENING DAY

ALKERMES COMPLETES $23M FINANCING IN LESS THAN A WEEK